CircRNA-regulated glucose metabolism in ovarian cancer: an emerging landscape for therapeutic intervention

被引:3
|
作者
Wang, Yaolong [1 ,2 ,3 ]
Chen, Xi [1 ,2 ,3 ]
Yang, Yongxiu [1 ,2 ,3 ]
机构
[1] Lanzhou Univ, Dept Obstet & Gynecol, Hosp 1, Lanzhou 730000, Peoples R China
[2] Key Lab Gynecol Oncol Gansu Prov, Lanzhou, Gansu, Peoples R China
[3] Lanzhou Univ, Clin Med Coll 1, Lanzhou, Gansu, Peoples R China
来源
CLINICAL & TRANSLATIONAL ONCOLOGY | 2024年 / 26卷 / 03期
关键词
CircRNA; Ovarian cancer; Targeted therapy; Glucose metabolism; EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULAR RNAS; CELLS; PROMOTES; TUMOR; EXPRESSION; PROLIFERATION; SUPPRESSION; METASTASIS; ACTIVATION;
D O I
10.1007/s12094-023-03285-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ovarian cancer (OC) has the highest mortality rate among female reproductive system tumours, with limited efficacy of traditional treatments and 5-year survival rates that rarely exceed 40%. Circular RNA (circRNA) is a stable endogenous circular RNA that typically regulates protein expression by binding to downstream miRNA. It has been demonstrated that circRNAs play an important role in the proliferation, migration, and glucose metabolism (such as the Warburg effect) of OC and can regulate the expression of glucose metabolism-related proteins such as GLUT1 and HK2, promoting anaerobic glycolysis of cancer cells, increasing glucose uptake and ATP production, and affecting energy supply and biosynthetic substances to support tumour growth and invasion. This review summarises the formation and characteristics of circRNAs and focuses on their role in regulating glucose metabolism in OC cells and their potential therapeutic value, providing insights for identifying new therapeutic targets.
引用
收藏
页码:584 / 596
页数:13
相关论文
共 50 条
  • [41] Overcoming cancer therapeutic resistance by targeting dysregulated glucose metabolism
    Zhao, Yuhua
    Zhou, Ming
    LeDoux, Susan
    Wilson, Glenn
    Yu, Dihua
    Price, Janet
    Fodstad, Oystein
    Tan, Ming
    CANCER RESEARCH, 2012, 72
  • [42] The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism
    Vanhove, Karolien
    Graulus, Geert-Jan
    Mesotten, Liesbet
    Thomeer, Michiel
    Derveaux, Elien
    Noben, Jean-Paul
    Guedens, Wanda
    Adriaensens, Peter
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [43] Emerging therapeutic potential of glycine in cardiometabolic diseases: dual benefits in lipid and glucose metabolism
    Rom, Oren
    Villacorta, Luis
    Zhang, Jifeng
    Chen, Y. Eugene
    Aviram, Michael
    CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (05) : 428 - 432
  • [44] Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies
    Zhang, Yi
    Li, Qiong
    Huang, Zhao
    Li, Bowen
    Nice, Edouard C.
    Huang, Canhua
    Wei, Liuya
    Zou, Bingwen
    CANCERS, 2022, 14 (19)
  • [45] Emerging genomic landscape and therapeutic targets in young patients with colorectal cancer (CRC).
    Lieu, Christopher Hanyoung
    Golemis, Erica
    Kim, Jihye
    Serebriiskii, Ilya
    Bailey, Mark
    Tan, Aik-Choon
    Pitts, Todd M.
    Eng, Cathy
    Ennis, Riley
    Eckhardt, S. Gail
    Frampton, Garrett Michael
    Meyer, Joshua E.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer
    Wang, Chenxi
    Yu, Chenxi
    Chang, Hongkai
    Song, Jiaqi
    Zhang, Shuai
    Zhao, Jianguo
    Wang, Jiyan
    Wang, Tao
    Qi, Qi
    Shan, Changliang
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2023, 27 (08) : 733 - 743
  • [47] Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives
    Irshad, Rasha
    Tabassum, Sazi
    Husain, Mohammad
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (12) : 1090 - 1103
  • [48] Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
    Mats Lambe
    Annette Wigertz
    Hans Garmo
    Göran Walldius
    Ingmar Jungner
    Niklas Hammar
    Cancer Causes & Control, 2011, 22 : 1163 - 1171
  • [49] Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer
    Lambe, Mats
    Wigertz, Annette
    Garmo, Hans
    Walldius, Goran
    Jungner, Ingmar
    Hammar, Niklas
    CANCER CAUSES & CONTROL, 2011, 22 (08) : 1163 - 1171
  • [50] Evolving landscape of detection and targeting miRNA/epigenetics for therapeutic strategies in ovarian cancer
    Bhowmik, Arpan Dey
    Shaw, Pallab
    Pillai, Mohan Shankar Gopinatha
    Rao, Geeta
    Dwivedi, Shailendra Kumar Dhar
    CANCER LETTERS, 2025, 611